Data collection extracted on a weekly basis week commencing 13 April 2020 | Revised weekly data collection. The first collection is due week commencing 28 September 2020 |
| |
All patients with defined long-term medical conditions which pose a COVID-19 risk, identified as clinically extremely vulnerable to that risk and/or on certain drug treatments as below: | All patients with defined long-term medical conditions which pose a COVID-19 risk, identified as clinically extremely vulnerable/potentially clinically vulnerable to that risk and/or on certain drug treatments as below: |
Medical Conditions that provide information on clinically vulnerable patients· Severe asthma and dust related lung disease with relevant treatment in the last 12 months (asthma treatment & prednisolone OR high dose cortiscosteroid safety card)· COPD emphysema, and associated lung diseases with relevant treatment in the last 12 months (COPD drugs OR high dose high dose cortiscosteroid safety card· Non-asthma and non-COPD respiratory disease· Cancer(haem and others)· Genetic, metabolic or autoimmune disease· Immunosuppression drugs in the last 12 months· Flu-like symptoms or respiratory tract infections from 1 November 2019· Transplants with severe Immunosuppression drug treatment in the last 12 months· Pregnant in last 9 months | Medical Conditions that provide information on clinically vulnerable patients· Severe asthma and dust related lung disease with relevant treatment in the last 12 months (asthma treatment & prednisolone OR high dose cortiscosteroid safety card)· COPD emphysema, and associated lung diseases with relevant treatment in the last 12 months (COPD drugs OR high dose high dose cortiscosteroid safety card· Non-asthma and non-COPD respiratory disease· Cancer(haem and others)· Genetic, metabolic or autoimmune disease· Immunosuppression drugs in the last 12 months· Flu-like symptoms or respiratory tract infections from 1 November 2019· Transplants with severe Immunosuppression drug treatment in the last 12 months· Pregnant in last 9 months No change |
· Patients designated separately as at risk from COVID-19 using high/medium/low risk SNOWED CT Codes, for example | · Patients designated separately as at risk from COVID-19 using high/medium/low risk SNOWED CT Codes, for example No change |
Patients with a COVID-19 activity code | Patients with a COVID-19 activity code No change |
| Clinically vulnerable patients (eligible for seasonal flu vaccination)· Chronic Respiratory disease· Unresolved asthma with recent asthma drug treatment (in the last 12 months) or has ever had an emergency hospital admission due to asthma· Chronic heart disease· Unresolved chronic kidney disease stage3,4 and 5· Unresolved diabetes mellitus· Unresolved immunosuppression diagnosis· Immunosuppression procedure in the last 12 months· Chronic Liver disease· Chronic neurological disease· Pregnant in the last 9 months (different cluster to clinically extremely vulnerable group)· In patients aged 16 and over : BMI of 40+ in the last 12 months· In patients aged 16 and over : Latest BMI in the last 3 years was 40+ · Learning disability (including Down’s)· Has a “requires flu vaccination” code· Identified as a healthcare worker in the last 12 months· Household contact of an immunocompromised individual Other Potentially clinically Vulnerable patients· Unresolved hypertension· Pulmonary hypertension· Dementia· Systemic lupus· Discoid and non-systemic lupus· Psoriasis· Rheumatoid arthritis and associated disorders |
| Additional Data items for Patients from the above groups· Latest ethnic category code (all groups)· Earliest code indicating that the patient has died (all groups)· Latest smoking status (all groups)· Blood pressure from the last 2 years (all groups)· In patients aged 16 and over: all BMI and weight in last 5 years plus height (all groups)· IFCC-HbA1c in the last 2 years (for diabetic patients in the flu group only)· Latest COPD resolved and admission codes (for COPD Patients in the clinically extreme vulnerable group only)· ACE inhibitors, ARBs and non-steroidal anti-inflammatory drugs in the last 12 months (all groups)· Latest asthma emergency admission codes (for asthma patients in flu group only)· Asthma-related drug treatments in the last 12 months (for asthma patients in the flu group only) |